スパーク病性パーキンソン病における自律神経障害進行の遅延予測因子としての脳脊髄液LRRK2
Shuai Chen1, Yu Shen2, Jingyu Shao1
1Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou 450003, China.
Autonomic neuroscience : basic & clinical
|February 28, 2026
まとめ
脳脊髄液(CSF)中のLRRK2タンパク質レベルは、パーキンソン病(PD)における自律神経障害の進行を予測する可能性がある。PD患者においてCSF中のLRRK2が高いほど、5年間で自律神経症状の悪化が遅いことと関連していた。
関連する概念動画
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K


